Disruptions of Brain Networks and Sleep by Electroconvulsive Therapy

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age21-65
SponsorWashington University School of Medicine

About this trial

Electroconvulsive therapy (ECT) alleviates treatment-resistant depression (TRD) through repeated generalized seizures. The goal of this study is to evaluate how ECT impacts sleep-wake regulation and efficiency of information transfer in functional networks in different states of arousal.

Eligibility criteria

Qualifiers

Referral for initial ECT index course for Treatment-Resistant Depression (TRD), unipolar major depressive disorder or bipolar depression. Historic failure of response or remission to at least two antidepressant medications of sufficient dose and duration will be used for TRD diagnostic.

Disqualifiers

Diagnoses of schizophrenia or schizoaffective disorders.

Subjects who are unable to tolerate the Dreem device for sleep recordings will be excluded from the study.

Trial design

Treatments tested in this trial

  • Electroencephalography (EEG)
  • Quantitative Measurements of Sleep Microstructure

Treatment groups

No treatment groups listed

Sponsors and collaborators

Washington University School of Medicine

Lead sponsor

National Institute of Mental Health (NIMH)

Collaborator